GlassScriptPhysician profile
Harjoth S Malli
NPI 1992994073
$3,245.82
in general payments reported to CMS, 2019-2025
13 companies · $1,032 in 2025
The $1,032 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $149 · 2021: $29.95 · 2022: $1,219 · 2023: $35.45 · 2024: $131 · 2025: $1,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $951 · Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $951.20 |
| Food and Beverage | $247.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,305.06 | 2022-2025 | Impella |
| Philips North America LLC | $1,036.12 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.98 | 2019-2020 | |
| Glaxosmithkline, LLC. | $176.87 | 2019-2020 | |
| Insmed, INC. | $109.30 | 2019 | |
| Janssen Pharmaceuticals, INC | $93.38 | 2019-2023 | Xarelto |
| Genentech USA, INC. | $73.14 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $71.90 | 2019-2020 | |
| Pfizer INC. | $63.73 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $43.03 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $21.74 | 2022 | |
| Inari Medical, INC. | $16.40 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $13.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harjoth Malli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.